Influence of HLA-DQA1*05 on the loss of response to anti-TNF treatment in inflammatory bowel disease. Spanish cohort of real clinical practice

被引：0
作者：
Perez, Jorge Perez [1 ]
Ortiz, Jaime Escobar [1 ]
Moreno, Ana Isabel Franco [2 ]
Santos, Maria del Rocio Plaza [1 ]
Pradillo, Marta Castillo [1 ]
Diaz, angel Ponferrada [1 ]
机构：
[1] Infanta Leonor Univ Hosp, Gastroenterol & Hepatol, Madrid, Spain
[2] Infanta Leonor Univ Hosp, Internal Med, Madrid, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2024年 / 47卷 / 08期
关键词：
D O I：
10.1016/j.gastrohep.2024.01.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：869 / 871
页数：3
相关论文
共 50 条
  • [21] Proactive Therapeutic drug monitoring of Infliximab, but not HLA-DQA1*05, predicts clinical outcome in inflammatory bowel disease
    Alonso, I.
    Carrillo Palau, M.
    Vera, B.
    Vela, M.
    Morant, A.
    Ramos, L.
    Reygosa, C.
    Medina Chico, J. S.
    Barrios, Y.
    Franco, A.
    Gutierrez-Nicolas, F.
    Jimenez, A.
    Hernandez-Guerra, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I597 - I597
  • [22] HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn's disease
    Sazonovs, A.
    Kennedy, N. A.
    Bewshea, C.
    Moutsianas, L.
    Walker, G. J.
    De lange, K.
    Goodhand, J.
    Anderson, C.
    Barrett, J.
    Ahmad, T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S9 - S10
  • [23] HLA-DQA1 CONTRIBUTES TO THE DEVELOPMENT OF ANTIBODIES TO ANTI-TNF THERAPY IN CROHN'S DISEASE
    Sazonovs, Aleksejs
    Kennedy, Nicholas A.
    Bewshea, Claire
    Moutsianas, Loukas
    Walker, Gareth J.
    De lange, Katrina
    Goodhand, James R.
    Anderson, Carl
    Barrett, Jeff
    Ahmad, Tariq
    GUT, 2018, 67 : A52 - A53
  • [24] HLA-DQA1 CONTRIBUTES TO THE DEVELOPMENT OF ANTIBODIES TO ANTI-TNF THERAPY IN CROHN'S DISEASE
    Sazonovs, Aleksejs
    Kennedy, Nicholas A.
    Bewshea, Claire M.
    Moutsianas, Loukas
    Walker, Gareth J.
    De Lange, Katrina
    Goodhand, James
    Anderson, Carl
    Barrett, Jeff
    Ahmad, Tariq
    GASTROENTEROLOGY, 2018, 154 (06) : S124 - S125
  • [25] Loss of response to anti-TNF in inflammatory bowel disease in a Portuguese centre
    Sousa, M.
    Silva, A. P.
    Rodrigues, A.
    Rodrigues, J.
    Silva, J.
    Gomes, C.
    Proenca, L.
    Carvalho, J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S313 - S314
  • [26] HLA-DQA1*05 detection in saliva, an effective alternative in the monitoring and control of patients with Inflammatory Bowel Disease
    Lavin Exposito, C.
    Bouhmidi Assakali, A.
    Rodriguez Romero, V.
    Cabanillas Navarro, M. L.
    Vozmediano Sanchez, P.
    Velasco del Burgo, M.
    Alanon Barba, M.
    Moraleda Cebrian, F.
    Hidalgo Juarez, M. L.
    Bonillo Merino, C.
    Pinilla Sanchez, J.
    Laguna Laguna, M. T.
    Saluena Saluena, I.
    Sanchez Pardo, A. M.
    Sanchez Alonso, M.
    Suarez, E. Barreto
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2227 - I2227
  • [27] Impact of HLA-DQA1*05 genotype in immunogenicity and response to treatment with Tumour Necrosis Factor-alpha Antagonists in Inflammatory Bowel Disease patients
    Torres, V. Moreno
    Mira, C.
    Madero-Velazquez, L.
    Munoz, R.
    Belen-Galipienso, O.
    Cameo, J., I
    Bernal, L.
    Garcia-Trueba, A.
    Sempere, L.
    Gutierrez-Casbas, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2352 - i2353
  • [28] Withdrawal of immunomodulatory therapy is feasible in anti-TNF treated patients with negative HLA-DQA1*05-an observational study
    Gonzalez, Haidee Aleman
    Whitehead, Emma
    Pattinson, Alison
    Stamp, Katie
    Turnbul, Jack
    Bautista, Nannet
    Robertson, Hayley
    Sebastian, Shaji
    GUT, 2023, 72 (SUPPL_2) : A102 - A102
  • [29] Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease
    Schultheiss, Johannes P. D.
    Mahmoud, Remi
    Louwers, Jonas M.
    van der Kaaij, Michiel T.
    van Hellemondt, Boris P.
    van Boeckel, Petra G.
    Mahmmod, Nofel
    Jharap, Bindia
    Fidder, Herma H.
    Oldenburg, Bas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (10) : 1298 - 1308
  • [30] HISPANIC IBD PATIENTS WITH HLA-DQA1*05 HAVE HIGHER RATES OF ANTI-TNF IMMUNOGENICITY COMPARED TO NON-CARRIERS
    Ioannou, Stephanie
    Beecham, Ashley Harris
    Gomez, Lissette
    Dauer, Ryan M.
    Khakoo, Nidah S.
    Pascual, Lauren
    Quintero, Maria
    Mills, Grechen
    Lopez, Joanna
    Leavitt, James S.
    Solis, Norma I.
    Deshpande, Amar R.
    Kerman, David H.
    Abreu, Maria T.
    McCauley, Jacob L.
    Damas, Oriana M.
    GASTROENTEROLOGY, 2021, 160 (06) : S72 - S72
12345